CVS Health Corp , Walgreens Boots Alliance Inc and Walmart Inc agreed to pay about $13.8 billion to resolve thousands of U.S. state and local lawsuits accusing the pharmacy chains of mishandling opioid pain drugs, potentially bringing years of litigation close to the finish line.
U.S. cannabis producer Green Thumb Industries Inc posted higher third-quarter sales and core profit on Wednesday, as strong demand in newly legalized New Jersey and home market Illinois helped ward off some of the hit from inflation.
The annual price of a newly-launched cancer drug in the United States averaged $283,000 last year, a 53% increase from 2017, according to a new report from U.S. Democratic Representative Katie Porter, a consumer bankruptcy law professor running for re-election in California.
Swiss drugs regulator Swissmedic said on Wednesday it is examining potential risks in connection with bubbles that appeared in vials of COVID-19 vaccine boosters retooled to target the Omicron variant of the coronavirus.
China is striving to control the sudden outbreak of COVID-19 infections in the shortest possible time, the health commission said on Wednesday in its first comments since the 20th Communist Party Congress as cases rise across major cities.
The father of a 3-year-old boy who died on Tuesday from carbon monoxide poisoning in northwest China said strict COVID-19 policies "indirectly killed" his son by causing delays obtaining treatment, in a case that has sparked social media outrage.
Humana Inc beat third-quarter profit estimates on Wednesday, as a sluggish recovery in elective procedures helped the health insurer keep medical costs in check.
CVS Health Corp on Wednesday forecast a 2023 profit below Wall Street estimates and said it hoped to mitigate the hit from a performance rating decline for its most popular Medicare plan by encouraging members to shift to other plans.
Medical device makers and scientists are working on new technologies to improve widely-used devices that assess potential heart and respiratory problems given mounting evidence that current ones could lead to inadequate healthcare for patients with darker skin.
